申请人:Bayer Schering Pharma Aktiengesellshaft
公开号:US07977485B2
公开(公告)日:2011-07-12
The invention relates to novel 2-heteroaryl carboxamides and to the use thereof for producing medicaments for the treatment and/or prophylaxis of diseases and for improving perception, concentration, learning and/or memory.
本发明涉及新的2-杂环芳基羧酰胺及其用于制备治疗和/或预防疾病以及改善感知、注意力、学习和/或记忆的药物。